Sort
130,381 grants matching “hiv”
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$892,889Mamta K Jain · Ut Southwestern Medical Center · U01 · FY2007 · AI
HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses
$892,826Parham Ramezani-Rad · La Jolla Institute For Immunology · R61 · FY2024 · AI
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSAL
$892,816Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R61 · FY2018 · DA
Center of Excellence for Health Disparities Research: EI Centro
$892,728Victoria B Mitrani · University Of Miami Coral Gables · P60 · FY2015 · MD
High Risk Drug Use &HIV-Learning from the NYC Epidemic
$892,721National Development &Res Institutes · P30 · FY2003 · DA
Biostatistics Resource
$892,675Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2012 · CA
Optimizing HIV Care in Less Developed Countries
$892,666Kenneth Alan Freedberg · Massachusetts General Hospital · R37 · FY2018 · AI
The effect of cytomegalovirus, inflammation, and immune activation on neurodevelopment in children exposed to maternal HIV infection
$892,566Jennifer Ann Slyker · University Of Washington · P01 · FY2022 · HD
Micro Analytical Immunochemistry
$892,557Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2024 · EB
Targeting beta-catenin to disrupt the T memory stem cell reservoir
$892,484Ann M Chahroudi · Emory University · R56 · FY2015 · AI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
$892,443Nicole Doria-Rose · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
$892,443Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
$892,443Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
$892,443Nicole Doria-Rose · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Core 5 - Virology, Cell, Molecular & Chemical Biology Core
$892,260Paul D Bieniasz · University Of Michigan At Ann Arbor · U54 · FY2021 · AI
Combined cytokine therapy for sustained HIV remission
$892,227Vijayakumar Velu · Emory University · R01 · FY2024 · AI
IMPAACT, RANDOMIZED TRIAL TO EVALUATE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT REGIMENTS IN HIV INFECTED WOMEN
$892,210Driver Barbara · Westat, Inc. · N01 · FY2018 · HD
Administrative Coordinating Core
$892,118Igor Grant · University Of California, San Diego · P50 · FY2017 · DA
ISS-ODN activation of tonsillar APCs to augment immunity
$892,001Melissa J Robbiani · Population Council · R01 · FY2006 · DE
SOUTH AFRICAN MEN HEALTH PROMOTION PROJECT
$892,000John Barton Jemmott · University Of Pennsylvania · R01 · FY2006 · HD
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
$891,969James L Abbruzzese · Duke University · UM1 · FY2016 · CA
2/6 COMpAAAS U01: Observation Study
$891,895Amy Caroline Justice · Yale University · U01 · FY2020 · AA
Combined cytokine therapy for sustained HIV remission
$891,856Vijayakumar Velu · Emory University · R01 · FY2020 · AI
A Mucosal Vaccine for HSV-2
$891,829Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2009 · AI
HIV Risk Reduction for Black Drug-Using Women
$891,825University Of Pennsylvania · R01 · FY2002 · MH